This paper reports on the consensus conference on the management of intra-abdominal infections (IAIs) which was held on July 23, 2016, in Dublin, Ireland, as a part of the annual World Society of Emergency Surgery (WSES) meeting. This document covers all aspects of the management of IAIs. The Grading of Recommendations Assessment, Development and Evaluation recommendation is used, and this document represents the executive summary of the consensus conference findings.

1st Department of Surgery Department of Abdominal Thoracic Surgery and Traumatology General University Hospital Praha Czech Republic

Abdominal Center University Hospital Meilahti Helsinki Finland

Acute Care Surgery The Queen's Medical Center Honolulu HI USA

American Board of Surgery Philadelphia PA USA

Département d'Anesthésie Réanimation CHU Bichat Claude Bernard HUPNVS Assistance Publique Hôpitaux de Paris University Denis Diderot Paris France

Department of Biomedical Sciences and Public Health Unit of Hygiene Preventive Medicine and Public Health UNIVPM Ancona Italy

Department of Critical Care Medicine Ghent University Hospital Ghent Belgium

Department of Emergency Surgery Maggiore Hospital Parma Italy

Department of Emergency Surgery Mozyr City Hospital Mozyr Belarus

Department of Gastrointestinal Surgery Stavanger University Hospital Stavanger Department of Clinical Medicine University of Bergen Bergen Norway

Department of General Surgery Division of Surgery Rambam Health Care Campus Haifa Israel

Department of General Visceral and Thoracic Surgery Klinikum Peine Academic Hospital of Medical University Hannover Hannover Germany

Department of Intensive Care Erasme Hospital Université libre de Bruxelles Brussels Belgium

Department of Surgery Academic Medical Centre Amsterdam Netherlands

Department of Surgery Assia Medical Group Tel Aviv University Sackler School of Medicine Tel Aviv Israel

Department of Surgery Catholic University of Sacred Heart Rome Italy

Department of Surgery College of Medicine and Health Sciences UAE University Al Ain United Arab Emirates

Department of Surgery Macerata Hospital Macerata Italy

Department of Surgery Maggiore Hospital Bologna Italy

Department of Surgery School of Medicine Washington University in Saint Louis St Louis MO USA

Department of Surgery University of Colorado Denver CO USA

Department of Surgery University of Washington Seattle WA USA

Department of Surgery UPMC University of Pittsburgh School of Medicine Pittsburgh PA USA

Departments of Surgery and Anesthesiology Division of Trauma and Surgical Critical Care Vanderbilt University Medical Center Nashville TN USA

Departments of Surgery Critical Care Medicine and the Regional Trauma Service Foothills Medical Centre Calgary AB Canada

Division of Trauma Surgery Department of Surgery School of Medical Sciences University of Campinas Campinas Brazil

Emergency Department Trauma Center Niguarda Hospital Milan Italy

Emergency post operative Department Otavio De Freitas Hospital and Osvaldo Cruz Hospital Recife Recife Brazil

General and Upper GI Surgery Queen Elizabeth Hospital Birmingham UK

General Surgery Department Medical University University Hospital St George Plovdiv Bulgaria

General Surgery Department Papa Giovanni XXIII Hospital Bergamo Italy

Infectious Diseases Unit Department of Medical and Surgical Sciences Sant'Orsola Hospital University of Bologna Bologna Italy

Intensive Care Unit University of Modena Modena Italy

Letterkenny University Hospital and Donegal Clinical Research Academy Letterkenny Ireland

Multidisciplinary Intensive Care Research Organization Wellcome Trust HRB Clinical Research Department of Clinical Medicine Trinity Centre for Health Sciences St James's University Hospital Dublin Ireland

Zobrazit více v PubMed

Guyatt G, Gutterman D, Baumann MH, Addrizzo-Harris D, Hylek EM, Phillips B, et al. Grading strength of recommendations and quality of evidence in clinical guidelines: report from an American College of Chest Physicians task force. Chest. 2006;129:174–81. doi: 10.1378/chest.129.1.174. PubMed DOI

Menichetti F, Sganga G. Definition and classification of intra-abdominal infections. J Chemother. 2009;21(Suppl 1):3–4. doi: 10.1179/joc.2009.21.Supplement-1.3. PubMed DOI

Andersen BR, Kallehave FL, Andersen HK. Antibiotics versus placebo for prevention of postoperative infection after appendicectomy. Cochrane Database Syst Rev. 2005;3:CD001439. PubMed PMC

Mazeh H, Mizrahi I, Dior U, Simanovsky N, Shapiro M, Freund HR, et al. Role of antibiotic therapy in mild acute calculus cholecystitis: a prospective randomized controlled trial. World J Surg. 2012;36:1750–9. doi: 10.1007/s00268-012-1572-6. PubMed DOI

Regimbeau JM, Fuks D, Pautrat K, Mauvais F, Haccart V, Msika S, et al. Effect of postoperative antibiotic administration on postoperative infection following cholecystectomy for acute calculous cholecystitis: a randomized clinical trial. JAMA. 2014;312:145–54. doi: 10.1001/jama.2014.7586. PubMed DOI

Sawyer RG, Claridge JA, Nathens AB, Rotstein OD, Duane TM, Evans HL, et al. Trial of short-course antimicrobial therapy for intraabdominal infection. N Engl J Med. 2015;372:1996–2005. doi: 10.1056/NEJMoa1411162. PubMed DOI PMC

Blot S, De Waele JJ, Vogelaers D. Essentials for selecting antimicrobial therapy for intra-abdominal infections. Drugs. 2012;72:e17–32. doi: 10.2165/11599800-000000000-00000. PubMed DOI PMC

Gupta S, Kaushik R. Peritonitis—the Eastern experience. World J Emerg Surg. 2006;1:13. doi: 10.1186/1749-7922-1-13. PubMed DOI PMC

Mishra SP, Tiwary SK, Mishra M, Gupta SK. An introduction of tertiary peritonitis. J Emerg Trauma Shock. 2014;7:121–3. doi: 10.4103/0974-2700.136872. PubMed DOI PMC

Reemst PH, van Goor H, Goris RJ. SIRS, MODS and tertiary peritonitis. Eur J Surg Suppl. 1996;576:47–8. PubMed

Lamme B, Mahler CW, van Ruler O, Gouma DJ, Reitsma JB, Boermeester MA. Clinical predictors of ongoing infection in secondary peritonitis: systematic review. World J Surg. 2006;30:2170–81. doi: 10.1007/s00268-005-0333-1. PubMed DOI

Montravers P, Dufour G, Guglielminotti J, Desmard M, Muller C, Houissa H, et al. Dynamic changes of microbial flora and therapeutic consequences in persistent peritonitis. Crit Care. 2015;19:70. doi: 10.1186/s13054-015-0789-9. PubMed DOI PMC

Cardoso T, Almeida M, Friedman ND, Aragão I, Costa-Pereira A, Sarmento E, et al. Classification of healthcare-associated infection: a systematic review 10 years after the first proposal. BMC Med. 2014;12:40. doi: 10.1186/1741-7015-12-40. PubMed DOI PMC

Seguin P, Fédun Y, Laviolle B, Nesseler N, Donnio PY, Mallédant Y. Risk factors for multidrug-resistant bacteria in patients with post-operative peritonitis requiring intensive care. J Antimicrob Chemother. 2010;65:342–6. doi: 10.1093/jac/dkp439. PubMed DOI

Augustin P, Kermarrec N, Muller-Serieys C, Lasocki S, Chosidow D, Marmuse JP, et al. Risk factors for multi drug resistant bacteria and optimization of empirical antibiotic therapy in postoperative peritonitis. Crit Care. 2010;14:R20. doi: 10.1186/cc8877. PubMed DOI PMC

Lee DS, Ryu JA, Chung CR, Yang J, Jeon K, Suh GY, et al. Risk factors for acquisition of multidrug-resistant bacteria in patients with anastomotic leakage after colorectal cancer surgery. Int J Colorectal Dis. 2015;30:497–504. doi: 10.1007/s00384-015-2161-6. PubMed DOI

Esteban A, Frutos-Vivar F, Ferguson ND, Peñuelas O, Lorente JA, Gordo F, et al. Sepsis incidence and outcome: contrasting the intensive care unit with the hospital ward. Crit Care Med. 2007;35:1284–9. doi: 10.1097/01.CCM.0000260960.94300.DE. PubMed DOI

Sartelli M, Abu-Zidan FM, Catena F, Griffiths EA, Di Saverio S, Coimbra R, et al. Global validation of the WSES Sepsis Severity Score for patients with complicated intraabdominal infections: a prospective multicenter study (WISS Study) World J Emerg Surg. 2015;10:61. doi: 10.1186/s13017-015-0055-0. PubMed DOI PMC

Singer M, Deutschman CS, Seymour CW, Shankar-Hari M, Annane D, Bauer M, et al. The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3) JAMA. 2016;315:801–10. doi: 10.1001/jama.2016.0287. PubMed DOI PMC

Bone RC, Balk RA, Cerra FB, Dellinger RP, Fein AM, Knaus WA, et al. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. Chest. 1992;101:1644–55. doi: 10.1378/chest.101.6.1644. PubMed DOI

Levy MM, Fink MP, Marshall JC, Abraham E, Angus D, Cook D, et al. 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. Crit Care Med. 2003;31:1250–6. doi: 10.1097/01.CCM.0000050454.01978.3B. PubMed DOI

Solomkin JS, Mazuski JE, Bradley JS, Rodvold KA, Goldstein EJ, Baron EJ, et al. Diagnosis and management of complicated intra-abdominal infection in adults and children: guidelines by the Surgical Infection Society and the Infectious Diseases Society of America. Surg Infect (Larchmt) 2010;11:79–109. doi: 10.1089/sur.2009.9930. PubMed DOI

Montravers P, Dupont H, Leone M, Constantin JM, Mertes PM, Société française d’anesthésie et de réanimation (Sfar) et al. Guidelines for management of intra-abdominal infections. Anaesth Crit Care Pain Med. 2015;34:117–30. doi: 10.1016/j.accpm.2015.03.005. PubMed DOI

Sandell E, Berg M, Sandblom G, Sundman J, Fränneby U, Boström L, et al. Surgical decision-making in acute appendicitis. BMC Surg. 2015;15:69. doi: 10.1186/s12893-015-0053-x. PubMed DOI PMC

Wagner JM, McKinney WP, Carpenter JL. Does this patient have appendicitis? JAMA. 1996;276:1589–94. doi: 10.1001/jama.1996.03540190061030. PubMed DOI

Doria AS, Moineddin R, Kellenberger CJ, Epelman M, Beyene J, Schuh S, et al. US or CT for diagnosis of appendicitis in children and adults? A meta-analysis Radiology. 2006;241:83–94. PubMed

Laméris W, van Randen A, van Es HW, van Heesewijk JP, van Ramshorst B, Bouma WH, et al. Imaging strategies for detection of urgent conditions in patients with acute abdominal pain: diagnostic accuracy study. BMJ. 2009;338:b2431. doi: 10.1136/bmj.b2431. PubMed DOI PMC

Carroll PJ, Gibson D, El-Faedy O, Dunne C, Coffey C, Hannigan A, et al. Surgeon-performed ultrasound at the bedside for the detection of appendicitis and gallstones: systematic review and meta-analysis. Am J Surg. 2013;205:102–8. doi: 10.1016/j.amjsurg.2012.02.017. PubMed DOI

Toorenvliet BR, Wiersma F, Bakker RF, Merkus JW, Breslau PJ, Hamming JF. Routine ultrasound and limited computed tomography for the diagnosis of acute appendicitis. World J Surg. 2010;34:2278–85. doi: 10.1007/s00268-010-0694-y. PubMed DOI PMC

Andeweg CS, Wegdam JA, Groenewoud J, van der Wilt GJ, van Goor H, Bleichrodt RP. Toward an evidence-based step-up approach in diagnosing diverticulitis. Scand J Gastroenterol. 2014;49:775–84. doi: 10.3109/00365521.2014.908475. PubMed DOI

Shah BR, Stewart J, Jeffrey RB, Olcott EW. Value of short-interval computed tomography when sonography fails to visualize the appendix and shows otherwise normal findings. J Ultrasound Med. 2014;33:1589–95. doi: 10.7863/ultra.33.9.1589. PubMed DOI

Koo HS, Kim HC, Yang DM, Kim SW, Park SJ, Ryu JK. Does computed tomography have any additional value after sonography in patients with suspected acute appendicitis? J Ultrasound Med. 2013;32:1397–403. doi: 10.7863/ultra.32.8.1397. PubMed DOI

Burke LM, Bashir MR, Miller FH, Siegelman ES, Brown M, Alobaidy M, et al. Magnetic resonance imaging of acute appendicitis in pregnancy: a 5-year multiinstitutional study. Am J Obstet Gynecol. 2015;213:693.e1–6. doi: 10.1016/j.ajog.2015.07.026. PubMed DOI

Duke E, Kalb B, Arif-Tiwari H, Daye ZJ, Gilbertson-Dahdal D, Keim SM, et al. A systematic review and meta-analysis of diagnostic performance of MRI for evaluation of acute appendicitis. AJR Am J Roentgenol. 2016;206:508–17. doi: 10.2214/AJR.15.14544. PubMed DOI

Stefanidis D, Richardson WS, Chang L, Earle DB, Fanelli RD. The role of diagnostic laparoscopy for acute abdominal conditions: an evidence-based review. Surg Endosc. 2009;23:16–23. doi: 10.1007/s00464-008-0103-x. PubMed DOI

Golash V, Willson PD. Early laparoscopy as a routine procedure in the management of acute abdominal pain: a review of 1,320 patients. Surg Endosc. 2005;19:882–5. doi: 10.1007/s00464-004-8866-1. PubMed DOI

Gaitán HG, Reveiz L, Farquhar C, Elias VM. Laparoscopy for the management of acute lower abdominal pain in women of childbearing age. Cochrane Database Syst Rev. 2014;5:CD007683. PubMed PMC

Shirah GR, O’Neill PJ. Intra-abdominal infections. Surg Clin North Am. 2014;94:1319–33. doi: 10.1016/j.suc.2014.08.005. PubMed DOI

Desserud KF, Veen T, Soreide K. Emergency general surgery in the geriatric patient. Br J Surg. 2016;103:e52–61. doi: 10.1002/bjs.10044. PubMed DOI

Aunan JR, Watson MM, Hagland HR, Søreide K. Molecular and biological hallmarks of ageing. Br J Surg. 2016;103:e29–46. doi: 10.1002/bjs.10053. PubMed DOI

Clegg A, Young J, Iliffe S, Rikkert MO, Rockwood K. Frailty in elderly people. Lancet. 2013;381:752–62. doi: 10.1016/S0140-6736(12)62167-9. PubMed DOI PMC

Robinson TN, Walston JD, Brummel NE, Deiner S, Brown CH, 4th, Kennedy M, et al. Frailty for surgeons: review of a National Institute on aging conference on frailty for specialists. J Am Coll Surg. 2015;221:1083–92. doi: 10.1016/j.jamcollsurg.2015.08.428. PubMed DOI PMC

Kenig J, Zychiewicz B, Olszewska U, Barczynski M, Nowak W. Six screening instruments for frailty in older patients qualified for emergency abdominal surgery. Arch Gerontol Geriatr. 2015;61:437–42. doi: 10.1016/j.archger.2015.06.018. PubMed DOI

Joseph B, Zangbar B, Pandit V, Fain M, Mohler MJ, Kulvatunyou N, et al. Emergency general surgery in the elderly: too old or too frail? J Am Coll Surg. 2016;222:805–13. doi: 10.1016/j.jamcollsurg.2016.01.063. PubMed DOI

Farhat JS, Velanovich V, Falvo AJ, Horst HM, Swartz A, Patton JH, Jr, et al. Are the frail destined to fail? Frailty index as predictor of surgical morbidity and mortality in the elderly. J Trauma Acute Care Surg. 2012;72:1526–30. doi: 10.1097/TA.0b013e3182542fab. PubMed DOI

Orouji Jokar T, Ibraheem K, Rhee P, Kulavatunyou N, Haider A, Phelan HA, et al. Emergency general surgery specific frailty index: a validation study. J Trauma Acute Care Surg. 2016;81:254–60. doi: 10.1097/TA.0000000000001120. PubMed DOI

Torres VB, Azevedo LC, Silva UV, Caruso P, Torelly AP, Silva E, et al. Sepsis-associated outcomes in critically ill patients with malignancies. Ann Am Thorac Soc. 2015;12:1185–92. PubMed

Kristjansson SR, Farinella E, Gaskell S, Audisio RA. Surgical risk and post-operative complications in older unfit cancer patients. Cancer Treat Rev. 2009;35:499–502. doi: 10.1016/j.ctrv.2009.04.004. PubMed DOI

Thorsen K, Soreide JA, Soreide K. What is the best predictor of mortality in perforated peptic ulcer disease? A population-based, multivariable regression analysis including three clinical scoring systems. J Gastrointest Surg. 2014;18:1261–8. doi: 10.1007/s11605-014-2485-5. PubMed DOI PMC

Boermeester MA, Humes DJ, Velmahos GC, Søreide K. Contemporary review of risk-stratified management in acute uncomplicated and complicated diverticulitis. World J Surg. 2016;40:2537–45. doi: 10.1007/s00268-016-3560-8. PubMed DOI

Neri A, Marrelli D, Scheiterle M, Di Mare G, Sforza S, Roviello F. Re-evaluation of Mannheim prognostic index in perforative peritonitis: prognostic role of advanced age. A prospective cohort study. Int J Surg. 2015;13:54–9. doi: 10.1016/j.ijsu.2014.11.035. PubMed DOI

Thorsen K, Soreide JA, Soreide K. Scoring systems for outcome prediction in patients with perforated peptic ulcer. Scand J Trauma Resusc Emerg Med. 2013;21:25. doi: 10.1186/1757-7241-21-25. PubMed DOI PMC

Finlayson E, Wang L, Landefeld CS, Dudley RA. Major abdominal surgery in nursing home residents: a national study. Ann Surg. 2011;254:921–6. doi: 10.1097/SLA.0b013e3182383a78. PubMed DOI PMC

Al-Temimi MH, Griffee M, Enniss TM, Preston R, Vargo D, Overton S, et al. When is death inevitable after emergency laparotomy? Analysis of the American College of Surgeons National Surgical Quality Improvement Program database. J Am Coll Surg. 2012;215:503–11. doi: 10.1016/j.jamcollsurg.2012.06.004. PubMed DOI

Soreide K, Desserud KF. Emergency surgery in the elderly: the balance between function, frailty, fatality and futility. Scand J Trauma Resusc Emerg Med. 2015;23:10. doi: 10.1186/s13049-015-0099-x. PubMed DOI PMC

Das K, Ozdogan M, Karateke F, Uzun AS, Sozen S, Ozdas S. Comparison of APACHE II, P-POSSUM and SAPS II scoring systems in patients underwent planned laparotomies due to secondary peritonitis. Ann Ital Chir. 2014;85:16–21. PubMed

Vincent JL, Moreno R, Takala J, Willatts S, De Mendonça A, Bruining H, et al. The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure. On behalf of the Working Group on Sepsis-Related Problems of the European Society of Intensive Care Medicine. Intensive Care Med. 1996;22:707–10. doi: 10.1007/BF01709751. PubMed DOI

Vincent JL, de Mendonça A, Cantraine F, Moreno R, Takala J, Suter PM, et al. Use of the SOFA score to assess the incidence of organ dysfunction/failure in intensive care units: results of a multicenter, prospective study. Working group on “sepsis-related problems” of the European Society of Intensive Care Medicine. Crit Care Med. 1998;26:1793–800. doi: 10.1097/00003246-199811000-00016. PubMed DOI

Biondo S, Ramos E, Fraccalvieri D, Kreisler E, Ragué JM, Jaurrieta E. Comparative study of left colonic Peritonitis Severity Score and Mannheim Peritonitis Index. Br J Surg. 2006;93:616–22. doi: 10.1002/bjs.5326. PubMed DOI

Rix TE, Bates T. Pre-operative risk scores for the prediction of outcome in elderly people who require emergency surgery. World J Emerg Surg. 2007;2:16. doi: 10.1186/1749-7922-2-16. PubMed DOI PMC

Møller MH, Engebjerg MC, Adamsen S, Bendix J, Thomsen RW. The Peptic Ulcer Perforation (PULP) score: a predictor of mortality following peptic ulcer perforation. A cohort study. Acta Anaesthesiol Scand. 2012;56:655–62. doi: 10.1111/j.1399-6576.2011.02609.x. PubMed DOI

Kologlu M, Elker D, Altun H, Sayek I. Validation of MPI and PIA II in two different groups of patients with secondary peritonitis. Hepatogastroenterology. 2001;48:147–51. PubMed

Billing A, Fröhlich D, Schildberg FW. Prediction of outcome using the Mannheim peritonitis index in 2003 patients. Br J Surg. 1994;81:209–13. doi: 10.1002/bjs.1800810217. PubMed DOI

Billing A, Fröhlich D, Mialkowskyj O, Stokstad P, Schildberg FW. Treatment of peritonitis with staged lavage: prognostic criteria and course of treatment. Langenbecks Arch Chir. 1992;377:305–13. PubMed

Wacha H, Hau T, Dittmer R, Ohmann C. Risk factors associated with intraabdominal infections: a prospective multicenter study. Peritonitis Study Group. Langenbecks Arch Surg. 1999;384:24–32. doi: 10.1007/s004230050169. PubMed DOI

Schneider CP, Seyboth C, Vilsmaier M, Küchenhoff H, Hofner B, Jauch KW, et al. Prognostic factors in critically ill patients suffering from secondary peritonitis: a retrospective, observational, survival time analysis. World J Surg. 2009;33:34–43. doi: 10.1007/s00268-008-9805-4. PubMed DOI

Tellor B, Skrupky LP, Symons W, High E, Micek ST, Mazuski JE. Inadequate source control and inappropriate antibiotics are key determinants of mortality in patients with intra-abdominal sepsis and associated bacteremia. Surg Infect (Larchmt) 2015;16:785–93. doi: 10.1089/sur.2014.166. PubMed DOI

Grunau G, Heemken R, Hau T. Predictors of outcome in patients with postoperative intra-abdominal infection. Eur J Surg. 1996;162:619–25. PubMed

Mulier S, Penninckx F, Verwaest C, Filez L, Aerts R, Fieuws S, et al. Factors affecting mortality in generalized postoperative peritonitis: multivariate analysis in 96 patients. World J Surg. 2003;27:379–84. doi: 10.1007/s00268-002-6705-x. PubMed DOI

De Waele JJ. Early source control in sepsis. Langenbecks Arch Surg. 2010;395:489–94. doi: 10.1007/s00423-010-0650-1. PubMed DOI

Rhodes A, Evans LE, Alhazzani W, Levy MM, Antonelli M, Ferrer R, et al. Surviving sepsis campaign: international guidelines for management of sepsis and septic shock: 2016. Intensive Care Med. 2017 Jan 18. PubMed

Sotto A, Lefrant JY, Fabbro-Peray P, Muller L, Tafuri J, Navarro F, et al. Evaluation of antimicrobial therapy management of 120 consecutive patients with secondary peritonitis. J Antimicrob Chemother. 2002;50:569–76. doi: 10.1093/jac/dkf167. PubMed DOI

Kim JJ, Liang MK, Subramanian A, Balentine CJ, Sansgiry S, Awad SS. Predictors of relaparotomy after nontrauma emergency general surgery with initial fascial closure. Am J Surg. 2011;202:549–52. doi: 10.1016/j.amjsurg.2011.06.023. PubMed DOI

Betsch A, Wiskirchen J, Trübenbach J, Manncke KH, Belka C, Claussen CD, et al. CT-guided percutaneous drainage of intra-abdominal abscesses: APACHE III score stratification of 1-year results. Eur Radiol. 2002;12:2883–9. PubMed

Bufalari A, Giustozzi G, Moggi L. Postoperative intraabdominal abscesses: percutaneous versus surgical treatment. Acta Chir Belg. 1996;96:197–200. PubMed

Theisen J, Bartels H, Weiss W, Berger H, Stein HJ, Siewert JR. Current concepts of percutaneous abscess drainage in postoperative retention. J Gastrointest Surg. 2005;9:280–3. doi: 10.1016/j.gassur.2004.04.008. PubMed DOI

Andersen JC, Bundgaard L, Elbrønd H, Laurberg S, Walker LR, Støvring J, Danish Surgical Society Danish national guidelines for treatment of diverticular disease. Dan Med J. 2012;59:C4453. PubMed

Ambrosetti P, Chautems R, Soravia C, Peiris-Waser N, Terrier F. Long-term outcome of mesocolic and pelvic diverticular abscesses of the left colon: a prospective study of 73 cases. Dis Colon Rectum. 2005;48:787–91. doi: 10.1007/s10350-004-0853-z. PubMed DOI

Brandt D, Gervaz P, Durmishi Y, Platon A, Morel P, Poletti PA. Percutaneous CT scan guided drainage versus antibiotherapy alone for Hinchey II diverticulitis: a case–control study. Dis Colon Rectum. 2006;49:1533–8. doi: 10.1007/s10350-006-0613-3. PubMed DOI

Siewert B, Tye G, Kruskal J, Sosna J, Opelka F, Raptopoulos V, et al. Impact of CT-guided drainage in the treatment of diverticular abscesses: size matters. Am J Roentgenol. 2006;186:680–6. doi: 10.2214/AJR.04.1708. PubMed DOI

Singh B, May K, Coltart I, Moore NR, Cunningham C. The long-term results of percutaneous drainage of diverticular abscess. Ann R Coll Surg Engl. 2008;90:297–301. doi: 10.1308/003588408X285928. PubMed DOI PMC

Dharmarajan S, Hunt SR, Birnbaum EH, Fleshman JW, Mutch MG. The efficacy of nonoperative management of acute complicated diverticulitis. Dis Colon Rectum. 2011;54:663–71. doi: 10.1007/DCR.0b013e31820ef759. PubMed DOI

Sallinen VJ, Mentula PJ, Leppäniemi AK. Nonoperative management of perforated diverticulitis with extraluminal air is safe and effective in selected patients. Dis Colon Rectum. 2014;57:875–81. doi: 10.1097/DCR.0000000000000083. PubMed DOI

Sartelli M, Catena F, Ansaloni L, Coccolini F, Griffiths EA, Abu-Zidan FM, et al. WSES Guidelines for the management of acute left sided colonic diverticulitis in the emergency setting. World J Emerg Surg. 2016;11:37. doi: 10.1186/s13017-016-0095-0. PubMed DOI PMC

Sallinen V, Akl EA, You JJ, Agarwal A, Shoucair S, Vandvik PO, et al. Meta-analysis of antibiotics versus appendicectomy for non-perforated acute appendicitis. Br J Surg. 2016;103:656–67. doi: 10.1002/bjs.10147. PubMed DOI PMC

Oliak D, Yamini D, Udani VM, Lewis RJ, Arnell T, Vargas H, et al. Initial nonoperative management for periappendiceal abscess. Dis Colon Rectum. 2001;44:936–41. doi: 10.1007/BF02235479. PubMed DOI

Brown CV, Abrishami M, Muller M, Velmahos GC. Appendiceal abscess: immediate operation or percutaneous drainage? Am Surg. 2003;69:829–32. PubMed

Kim JK, Ryoo S, Oh HK, Kim JS, Shin R, Choe EK, et al. Management of appendicitis presenting with abscess or mass. J Korean Soc Coloproctol. 2010;26:413–9. doi: 10.3393/jksc.2010.26.6.413. PubMed DOI PMC

Simillis C, Symeonides P, Shorthouse AJ, Tekkis PP. A meta-analysis comparing conservative treatment versus acute appendectomy for complicated appendicitis (abscess or phlegmon) Surgery. 2010;147:818–29. doi: 10.1016/j.surg.2009.11.013. PubMed DOI

Cao F, Li J, Li A, Fang Y, Wang YJ, Li F. Nonoperative management for perforated peptic ulcer: who can benefit? Asian J Surg. 2014;37:148–53. doi: 10.1016/j.asjsur.2013.10.002. PubMed DOI

Crofts TJ, Park KG, Steele RJ, Chung SS, Li AK. A randomized trial of nonoperative treatment for perforated peptic ulcer. N Engl J Med. 1989;320:970–3. doi: 10.1056/NEJM198904133201504. PubMed DOI

Marshall C, Ramaswamy P, Bergin FG, Rosenberg IL, Leaper DJ. Evaluation of a protocol for the non-operative management of perforated peptic ulcer. Br J Surg. 1999;86:131–4. doi: 10.1046/j.1365-2168.1999.00982.x. PubMed DOI

Gul YA, Shine MF, Lennon F. Non-operative management of perforated duodenal ulcer. Ir J Med Sci. 1999;168:254–6. doi: 10.1007/BF02944352. PubMed DOI

Sartelli M, Viale P, Catena F, Ansaloni L, Moore E, Malangoni M, et al. 2013 WSES guidelines for management of intra-abdominal infections. World J Emerg Surg. 2013;8:3. doi: 10.1186/1749-7922-8-3. PubMed DOI PMC

Coccolini F, Tranà C, Sartelli M, Catena F, Di Saverio S, Manfredi R, et al. Laparoscopic management of intra-abdominal infections: systematic review of the literature. World J Gastrointest Surg. 2015;7:160–9. doi: 10.4240/wjgs.v7.i8.160. PubMed DOI PMC

Di Saverio S, Birindelli A, Kelly MD, Catena F, Weber DG, Sartelli M, et al. WSES Jerusalem guidelines for diagnosis and treatment of acute appendicitis. World J Emerg Surg. 2016;11:34. doi: 10.1186/s13017-016-0090-5. PubMed DOI PMC

Sauerland S, Jaschinski T, Neugebauer EA. Laparoscopic versus open surgery for suspected appendicitis. Cochrane Database Syst Rev. 2010;10:CD001546. PubMed

Wilasrusmee C, Sukrat B, McEvoy M, Attia J, Thakkinstian A. Systematic review and meta-analysis of safety of laparoscopic versus open appendicectomy for suspected appendicitis in pregnancy. Br J Surg. 2012;99:1470–8. doi: 10.1002/bjs.8889. PubMed DOI PMC

Cheng HT, Wang YC, Lo HC, Su LT, Soh KS, Tzeng CW, et al. Laparoscopic appendectomy versus open appendectomy in pregnancy: a population-based analysis of maternal outcome. Surg Endosc. 2015;29:1394–9. doi: 10.1007/s00464-014-3810-5. PubMed DOI

Sanabria A, Villegas MI, Morales Uribe CH. Laparoscopic repair for perforated peptic ulcer disease. Cochrane Database Syst Rev. 2013;2:CD004778. PubMed PMC

Ansaloni L, Pisano M, Coccolini F, Peitzmann AB, Fingerhut A, Catena F, et al. 2016 WSES guidelines on acute calculous cholecystitis. World J Emerg Surg. 2016;11:25. doi: 10.1186/s13017-016-0082-5. PubMed DOI PMC

Kiviluoto T, Sirén J, Luukkonen P, Kivilaakso E. Randomised trial of laparoscopic versus open cholecystectomy for acute and gangrenous cholecystitis. Lancet. 1998;351:321–5. doi: 10.1016/S0140-6736(97)08447-X. PubMed DOI

Johansson M, Thune A, Nelvin L, Stiernstam M, Westman B, Lundell L. Randomized clinical trial of open versus laparoscopic cholecystectomy in the treatment of acute cholecystitis. Br J Surg. 2005;92:44–9. doi: 10.1002/bjs.4836. PubMed DOI

Kum CK, Goh PMY, Isaac JR, Tekant Y, Ngoi SS. Laparoscopic cholecystectomy for acute cholecystitis. Br J Surg. 1994;81:1651–4. doi: 10.1002/bjs.1800811130. PubMed DOI

Pessaux P, Regenet N, Tuech JJ, Rouge C, Bergamaschi R, Arnaud JP. Laparoscopic versus open cholecystectomy: a prospective comparative study in the elderly with acute cholecystitis. Surg Laparosc Endosc Percutan Tech. 2001;11:252–5. doi: 10.1097/00129689-200108000-00005. PubMed DOI

Lujan JA, Parrilla P, Robles R, Marin P, Torralba JA, Garcia-Ayllon J. Laparoscopic cholecystectomy vs open cholecystectomy in the treatment of acute cholecystitis: a prospective study. Arch Surg. 1998;133:173–5. doi: 10.1001/archsurg.133.2.173. PubMed DOI

Coccolini F, Catena F, Pisano M, Gheza F, Fagiuoli S, Di Saverio S, et al. Open versus laparoscopic cholecystectomy in acute cholecystitis. Systematic review and meta-analysis. Int J Surg. 2015;18:196–204. doi: 10.1016/j.ijsu.2015.04.083. PubMed DOI

Angenete E, Thornell A, Burcharth J, Pommergaard HC, Skullman S, Bisgaard T, et al. Laparoscopic lavage is feasible and safe for the treatment of perforated diverticulitis with purulent peritonitis: the first results from the randomized controlled trial DILALA. Ann Surg. 2016;263:117–22. doi: 10.1097/SLA.0000000000001061. PubMed DOI PMC

Schultz JK, Yaqub S, Wallon C, Blecic L, Forsmo HM, Folkesson J, et al. Laparoscopic lavage vs primary resection for acute perforated diverticulitis: the SCANDIV randomized clinical trial. JAMA. 2015;314:1364–75. doi: 10.1001/jama.2015.12076. PubMed DOI

Vennix S, Musters GD, Mulder IM, Swank HA, Consten EC, Belgers EH, et al. Laparoscopic peritoneal lavage or sigmoidectomy for perforated diverticulitis with purulent peritonitis: a multicentre, parallel-group, randomised, open-label trial. Lancet. 2015;386:1269–77. doi: 10.1016/S0140-6736(15)61168-0. PubMed DOI

Ceresoli M, Coccolini F, Montori G, Catena F, Sartelli M, Ansaloni L. Laparoscopic lavage versus resection in perforated diverticulitis with purulent peritonitis: a meta-analysis of randomized controlled trials. World J Emerg Surg. 2016;11:42. doi: 10.1186/s13017-016-0103-4. PubMed DOI PMC

Vennix S, Boersema GS, Buskens CJ, Menon AG, Tanis PJ, Lange JF, et al. Emergency laparoscopic sigmoidectomy for perforated diverticulitis with generalised peritonitis: a systematic review. Dig Surg. 2016;33:1–7. doi: 10.1159/000441150. PubMed DOI

Koperna T, Schulz F. Relaparotomy in peritonitis: prognosis and treatment of patients with persisting intraabdominal infection. World J Surg. 2000;24:32–7. doi: 10.1007/s002689910007. PubMed DOI

Van Ruler O, Lamme B, de Vos R, Obertop H, Reitsma JB, Boermeester MA. Decision making for relaparotomy in secondary peritonitis. Dig Surg. 2008;25:339–46. doi: 10.1159/000158911. PubMed DOI

Van Ruler O, Mahler CW, Boer KR, Reuland EA, Gooszen HG, Opmeer BC, et al. Comparison of on-demand vs planned relaparotomy strategy in patients with severe peritonitis: a randomized trial. JAMA. 2007;298:865–72. doi: 10.1001/jama.298.8.865. PubMed DOI

Weber DG, Bendinelli C, Balogh ZJ. Damage control surgery for abdominal emergencies. Br J Surg. 2014;101:e109–18. doi: 10.1002/bjs.9360. PubMed DOI

Stone HH, Strom PR, Mullins RJ. Management of the major coagulopathy with onset during laparotomy. Ann Surg. 1983;197:532–5. doi: 10.1097/00000658-198305000-00005. PubMed DOI PMC

Burch JM, Ortiz VB, Richardson RJ, Martin RR, Mattox KL, Jordan GL., Jr Abbreviated laparotomy and planned reoperation for critically injured patients. Ann Surg. 1992;215:476–83. doi: 10.1097/00000658-199205000-00010. PubMed DOI PMC

Sartelli M, Abu-Zidan FM, Ansaloni L, Bala M, Beltrán MA, Biffl WL, et al. The role of the open abdomen procedure in managing severe abdominal sepsis: WSES position paper. World J Emerg Surg. 2015;10:35. doi: 10.1186/s13017-015-0032-7. PubMed DOI PMC

Robledo FA, Luque-de-León E, Suárez R, Sánchez P, de-la-Fuente M, Vargas A, et al. Open versus closed management of the abdomen in the surgical treatment of severe secondary peritonitis: a randomized clinical trial. Surg Infect (Larchmt) 2007;8:63–72. doi: 10.1089/sur.2006.8.016. PubMed DOI

Kirkpatrick AW, Roberts DJ, De Waele J, Jaeschke R, Malbrain ML, De Keulenaer B, Pediatric Guidelines Sub-Committee for the World Society of the Abdominal Compartment Syndrome et al. Intra-abdominal hypertension and the abdominal compartment syndrome: updated consensus definitions and clinical practice guidelines from the World Society of the Abdominal Compartment Syndrome. Intensive Care Med. 2013;39:1190–206. doi: 10.1007/s00134-013-2906-z. PubMed DOI PMC

Bleszynski MS, Chan T, Buczkowski AK. Open abdomen with negative pressure device vs primary abdominal closure for the management of surgical abdominal sepsis: a retrospective review. Am J Surg. 2016;211:926–32. doi: 10.1016/j.amjsurg.2016.01.012. PubMed DOI

Demetriades D, Salim A. Management of the open abdomen. Surg Clin North Am. 2014;94:131–53. doi: 10.1016/j.suc.2013.10.010. PubMed DOI

Regner JL, Kobayashi L, Coimbra R. Surgical strategies for management of the open abdomen. World J Surg. 2012;36:497–510. doi: 10.1007/s00268-011-1203-7. PubMed DOI

Godat L, Kobayashi L, Costantini T, Coimbra R. Abdominal damage control surgery and reconstruction: world society of emergency surgery position paper. World J Emerg Surg. 2013;8. PubMed PMC

Atema JJ, Gans SL, Boermeester MA. Systematic review and meta-analysis of the open abdomen and temporary abdominal closure techniques in non-trauma patients. World J Surg. 2015;39:912–25. doi: 10.1007/s00268-014-2883-6. PubMed DOI

Kirkpatrick AW, Roberts DJ, Faris PD, Ball CG, Kubes P, Tiruta C, et al. Active negative pressure peritoneal therapy after abbreviated laparotomy: the intraperitoneal vacuum randomized controlled trial. Ann Surg. 2015;262:38–46. doi: 10.1097/SLA.0000000000001095. PubMed DOI PMC

Montravers P, Augustin P, Grall N, Desmard M, Allou N, Marmuse JP, et al. Characteristics and outcomes of anti-infective de-escalation during health care-associated intra-abdominal infections. Crit Care. 2016;20:83. doi: 10.1186/s13054-016-1267-8. PubMed DOI PMC

Tabah A, Cotta MO, Garnacho-Montero J, Schouten J, Roberts JA, Lipman J, et al. A systematic review of the definitions, determinants, and clinical outcomes of antimicrobial de-escalation in the intensive care unit. Clin Infect Dis. 2016;62:1009–17. doi: 10.1093/cid/civ1199. PubMed DOI

Gladman MA, Knowles CH, Gladman LJ, Payne JG. Intra-operative culture in appendicitis: traditional practice challenged. Ann R Coll Surg Engl. 2004;86:196–201. doi: 10.1308/003588404323043346. PubMed DOI PMC

Davies HO, Alkhamesi NA, Dawson PM. Peritoneal fluid culture in appendicitis: review in changing times. Int J Surg. 2010;8:426–9. doi: 10.1016/j.ijsu.2010.06.016. PubMed DOI

Sartelli M, Weber DG, Ruppé E, Bassetti M, Wright BJ, Ansaloni L, et al. Antimicrobials: a global alliance for optimizing their rational use in intra-abdominal infections (AGORA) World J Emerg Surg. 2016;11:33. doi: 10.1186/s13017-016-0089-y. PubMed DOI PMC

Jeon HG, Ju HU, Kim GY, Jeong J, Kim MH, Jun JB. Bacteriology and changes in antibiotic susceptibility in adults with community-acquired perforated appendicitis. PLoS One. 2014;9:e111144. doi: 10.1371/journal.pone.0111144. PubMed DOI PMC

Van Ruler O, Kiewiet JJ, Van Ketel RJ, Boermeester MA, Dutch Peritonitis Study Group Initial microbial spectrum in severe secondary peritonitis and relevance for treatment. Eur J Clin Microbiol Infect Dis. 2012;31:671–82. doi: 10.1007/s10096-011-1357-0. PubMed DOI PMC

Al-Hasan MN, Eckel-Passow JE, Baddour LM. Impact of healthcare-associated acquisition on community-onset Gram-negative bloodstream infection: a population-based study. Eur J Clin Microbiol Infect Dis. 2012;31:1163–71. doi: 10.1007/s10096-011-1424-6. PubMed DOI PMC

Swenson BR, Metzger R, Hedrick TL, McElearney ST, Evans HL, Smith RL, et al. Choosing antibiotics for intra-abdominal infections: what do we mean by “high risk”? Surg Infect (Larchmt) 2009;10:29–39. doi: 10.1089/sur.2007.041. PubMed DOI PMC

Chong YP, Bae IG, Lee SR, Chung JW, Jun JB, Choo EJ, et al. Clinical and economic consequences of failure of initial antibiotic therapy for patients with community-onset complicated intra-abdominal infections. PLoS One. 2015;10:e0119956. doi: 10.1371/journal.pone.0119956. PubMed DOI PMC

Steinbach CL, Töpper C, Adam T, Kees MG. Spectrum adequacy of antibiotic regimens for secondary peritonitis: a retrospective analysis in intermediate and intensive care unit patients. Ann Clin Microbiol Antimicrob. 2015;14:48. doi: 10.1186/s12941-015-0110-4. PubMed DOI PMC

McDonald LC. Trends in antimicrobial resistance in health care-associated pathogens and effect on treatment. Clin Infect Dis. 2006;42(Suppl 2):S65–S71. doi: 10.1086/499404. PubMed DOI

Riché FC, Dray X, Laisné MJ, Matéo J, Raskine L, Sanson-Le Pors MJ, et al. Factors associated with septic shock and mortality in generalized peritonitis: comparison between community-acquired and postoperative peritonitis. Crit Care. 2009;13:R99. doi: 10.1186/cc7931. PubMed DOI PMC

Shani V, Muchtar E, Kariv G, Robenshtok E, Leibovici L. Systematic review and meta-analysis of the efficacy of appropriate empiric antibiotic therapy for sepsis. Antimicrob Agents Chemother. 2010;54:4851–63. doi: 10.1128/AAC.00627-10. PubMed DOI PMC

Ferrer R, Artigas A, Suarez D, Palencia E, Levy MM, Arenzana A, Edusepsis Study Group et al. Effectiveness of treatments for severe sepsis: a prospective, multicenter, observational study. Am J Respir Crit Care Med. 2009;180:861–6. doi: 10.1164/rccm.200812-1912OC. PubMed DOI

Castellanos-Ortega A, Suberviola B, García-Astudillo LA, Holanda MS, Ortiz F, Llorca J, et al. Impact of the Surviving Sepsis Campaign protocols on hospital length of stay and mortality in septic shock patients: results of a three-year follow-up quasi-experimental study. Crit Care Med. 2010;38:1036–43. doi: 10.1097/CCM.0b013e3181d455b6. PubMed DOI

Puskarich MA, Trzeciak S, Shapiro NI, Arnold RC, Horton JM, Studnek JR, et al. Association between timing of antibiotic administration and mortality from septic shock in patients treated with a quantitative resuscitation protocol. Crit Care Med. 2011;39:2066–71. doi: 10.1097/CCM.0b013e31821e87ab. PubMed DOI PMC

Dellinger RP, Levy MM, Rhodes A, Annane D, Gerlach H, Opal SM, et al. Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock, 2012. Intensive Care Med. 2013;39:165–228. doi: 10.1007/s00134-012-2769-8. PubMed DOI PMC

de Ruiter J, Weel J, Manusama E, Kingma WP, Van der Voort PH. The epidemiology of intra-abdominal flora in critically ill patients with secondary and tertiary abdominal sepsis. Infection. 2009;37:522–7. doi: 10.1007/s15010-009-8249-6. PubMed DOI

Taccone FS, Laterre PF, Dugernier T, Spapen H, Delattre I, Wittebole X, et al. Insufficient β-lactam concentrations in the early phase of severe sepsis and septic shock. Crit Care. 2010;14:R126. doi: 10.1186/cc9091. PubMed DOI PMC

Plachouras D, Karvanen M, Friberg LE, Papadomichelakis E, Antoniadou A, Tsangaris I, et al. Population pharmacokinetic analysis of colistin methanesulfonate and colistin after intravenous administration in critically ill patients with infections caused by gram-negative bacteria. Antimicrob Agents Chemother. 2009;53:3430–6. doi: 10.1128/AAC.01361-08. PubMed DOI PMC

Dulhunty JM, Roberts JA, Davis JS, Webb SA, Bellomo R, Gomersall C, et al. Continuous infusion of beta-lactam antibiotics in severe sepsis: a multicenter double-blind, randomized controlled trial. Clin Infect Dis. 2013;56:236–44. doi: 10.1093/cid/cis856. PubMed DOI

Dulhunty JM, Roberts JA, Davis JS, Webb SA, Bellomo R, Gomersall C, et al. A multicenter randomized trial of continuous versus intermittent beta-lactam infusion in severe sepsis. Am J Respir Crit Care Med. 2015;192:1298–305. doi: 10.1164/rccm.201505-0857OC. PubMed DOI

Lodise TP, Jr, Lomaestro B, Drusano GL. Piperacillin-tazobactam for Pseudomonas aeruginosa infection: clinical implications of an extended-infusion dosing strategy. Clin Infect Dis. 2007;44:357–63. doi: 10.1086/510590. PubMed DOI

Lorente L, Jiménez A, Martín MM, Iribarren JL, Jiménez JJ, Mora ML. Clinical cure of ventilator-associated pneumonia treated with piperacillin/tazobactam administered by continuous or intermittent infusion. Int J Antimicrob Agents. 2009;33:464–8. doi: 10.1016/j.ijantimicag.2008.10.025. PubMed DOI

Freeman CD, Nicolau DP, Belliveau PP, Nightingale CH. Once-daily dosing of aminoglycosides: review and recommendations for clinical practice. J Antimicrob Chemother. 1997;39:677–86. doi: 10.1093/jac/39.6.677. PubMed DOI

Schuts EC, Hulscher ME, Mouton JW, Verduin CM, Stuart JW, Overdiek HW, et al. Current evidence on hospital antimicrobial stewardship objectives: a systematic review and meta-analysis. Lancet Infect Dis. 2016;16:847–56. doi: 10.1016/S1473-3099(16)00065-7. PubMed DOI

Klevens RM, Morrison MA, Nadle J, Petit S, Gershman K, Ray S, et al. Invasive methicillin-resistant Staphylococcus aureus infections in the United States. JAMA. 2007;298:1763–71. doi: 10.1001/jama.298.15.1763. PubMed DOI

Buijk SL, Gyssens IC, Mouton JW, Van Vliet A, Verbrugh HA, Bruining HA. Pharmacokinetics of ceftazidime in serum and peritoneal exudate during continuous versus intermittent administration to patients with severe intra-abdominal infections. J Antimicrob Chemother. 2002;49:121–8. doi: 10.1093/jac/49.1.121. PubMed DOI

Dahyot-Fizelier C, Lefeuvre S, Laksiri L, Marchand S, Sawchuk RJ, Couet W, et al. Kinetics of imipenem distribution into the peritoneal fluid of patients with severe peritonitis studied by microdialysis. Clin Pharmacokinet. 2010;49:323–34. doi: 10.2165/11319370-000000000-00000. PubMed DOI

Karjagin J, Lefeuvre S, Oselin K, Kipper K, Marchand S, Tikkerberi A, et al. Pharmacokinetics of meropenem determined by microdialysis in the peritoneal fluid of patients with severe peritonitis associated with septic shock. Clin Pharmacol Ther. 2008;83:452–9. doi: 10.1038/sj.clpt.6100312. PubMed DOI

Seguin P, Verdier MC, Chanavaz C, Engrand C, Laviolle B, Donnio PY, et al. Plasma and peritoneal concentration following continuous infusion of cefotaxime in patients with secondary peritonitis. J Antimicrob Chemother. 2009;63:564–7. doi: 10.1093/jac/dkn522. PubMed DOI

Ikawa K, Morikawa N, Hayato S, Ikeda K, Ohge H, Sueda T. Pharmacokinetic and pharmacodynamic profiling of cefepime in plasma and peritoneal fluid of abdominal surgery patients. Int J Antimicrob Agents. 2007;30:270–3. doi: 10.1016/j.ijantimicag.2007.04.012. PubMed DOI

Scheetz MH, Reddy P, Nicolau DP, Noskin GA, Postelnick MJ, Stosor V, et al. Peritoneal fluid penetration of tigecycline. Ann Pharmacother. 2006;40:2064–7. doi: 10.1345/aph.1H229. PubMed DOI

Eckmann C, Solomkin J. Ceftolozane/tazobactam for the treatment of complicated intra-abdominal infections. Expert Opin Pharmacother. 2015;16:271–80. doi: 10.1517/14656566.2015.994504. PubMed DOI

Solomkin J, Hershberger E, Miller B, Popejoy M, Friedland I, Steenbergen J, et al. Ceftolozane/tazobactam plus metronidazole for complicated intra-abdominal infections in an era of multidrug resistance: results from a randomized, double-blind, phase 3 trial (ASPECT-cIAI) Clin Infect Dis. 2015;60:1462–71. PubMed PMC

Mawal Y, Critchley IA, Riccobene TA, Talley AK. Ceftazidime-avibactam for the treatment of complicated urinary tract infections and complicated intra-abdominal infections. Expert Rev Clin Pharmacol. 2015;8:691–707. doi: 10.1586/17512433.2015.1090874. PubMed DOI

Mazuski JE, Gasink LB, Armstrong J, Broadhurst H, Stone GG, Rank D, et al. Efficacy and safety of ceftazidime-avibactam plus metronidazole versus meropenem in the treatment of complicated intra-abdominal infection–results from a randomized, controlled, double-blind, phase 3 program. Clin Infect Dis. 2016;62:1380–9. doi: 10.1093/cid/ciw133. PubMed DOI PMC

Ortega M, Marco F, Soriano A, Almela M, Martínez JA, Muñoz A, et al. Analysis of 4758 Escherichia coli bacteraemia episodes: predictive factors for isolation of an antibiotic-resistant strain and their impact on the outcome. J Antimicrob Chemother. 2009;63:568–74. doi: 10.1093/jac/dkn514. PubMed DOI

Goldstein EJ, Solomkin JS, Citron DM, Alder JD. Clinical efficacy and correlation of clinical outcomes with in vitro susceptibility for anaerobic bacteria in patients with complicated intra-abdominal infections treated with moxifloxacin. Clin Infect Dis. 2011;53:1074–80. doi: 10.1093/cid/cir664. PubMed DOI

Chen CW, Ming CC, Ma CJ, Shan YS, Yeh YS, Wang JY. Prospective, randomized, study of ampicillin-sulbactam versus moxifloxacin monotherapy for the treatment of community-acquired complicated intra-abdominal infections. Surg Infect (Larchmt) 2013;14:389–96. doi: 10.1089/sur.2012.017. PubMed DOI

Sartelli M, Catena F, Ansaloni L, Coccolini F, Corbella D, Moore EE, et al. Complicated intra-abdominal infections worldwide: the definitive data of the CIAOW study. World J Emerg Surg. 2014;9:37. doi: 10.1186/1749-7922-9-37. PubMed DOI PMC

Zalacain M, Biedenbach DJ, Badal RE, Young K, Motyl M, Sahm DF. Pathogen prevalence and antimicrobial susceptibility among enterobacteriaceae causing hospital-associated intra-abdominal infections in adults in the United States (2012–2013) Clin Ther. 2016;38:1510–21. doi: 10.1016/j.clinthera.2016.04.035. PubMed DOI

Ben-Ami R, Rodriguez-Bano J, Arsian H, Pitout JD, Quentin C, Calbo ES, et al. A multinational survey of risk factors for infection with extended-spectrum β-lactamase-producing Enterobacteriaceae in non-hospitalized patients. Clin Infect Dis. 2009;49:682–90. doi: 10.1086/604713. PubMed DOI

Morrissey I, Hackel M, Badal R, Bouchillon S, Hawser S, Biedenbach D. A review of ten years of the study for monitoring antimicrobial resistance trends (SMART) from 2002 to 2011. Pharmaceuticals (Basel) 2013;6:1335–46. doi: 10.3390/ph6111335. PubMed DOI PMC

Patel N, Harrington S, Dihmess A, Woo B, Masoud R, Martis P, et al. Clinical epidemiology of carbapenem-intermediate or -resistant Enterobacteriaceae. J Antimicrob Chemother. 2011;66:1600–8. doi: 10.1093/jac/dkr156. PubMed DOI

Lepper PM, Grusa E, Reichl H, Högel J, Trautmann M. Consumption of imipenem correlates with beta-lactam resistance in Pseudomonas aeruginosa. Antimicrob Agents Chemother. 2002;46:2920–5. doi: 10.1128/AAC.46.9.2920-2925.2002. PubMed DOI PMC

Perez F, Bonomo RA. Can we really use ß-lactam/ß-lactam inhibitor combinations for the treatment of infections caused by extended-spectrum ß-lactamase-producing bacteria? Clin Infect Dis. 2012;54:175–7. doi: 10.1093/cid/cir793. PubMed DOI

Gutiérrez-Gutiérrez B, Pérez-Galera S, Salamanca E, de Cueto M, Calbo E, Almirante B, et al. A multinational, preregistered cohort study of β-Lactam/β-lactamase inhibitor combinations for treatment of bloodstream infections due to extended-spectrum-β-lactamase-producing Enterobacteriaceae. Antimicrob Agents Chemother. 2016;60:4159–69. doi: 10.1128/AAC.00365-16. PubMed DOI PMC

Montravers P, Dupont H, Bedos JP, Bret P, Tigecycline Group Tigecycline use in critically ill patients: a multicentre prospective observational study in the intensive care setting. Intensive Care Med. 2014;40:988–97. doi: 10.1007/s00134-014-3323-7. PubMed DOI PMC

Eckmann C, Montravers P, Bassetti M, Bodmann KF, Heizmann WR, Sánchez García M, et al. Efficacy of tigecycline for the treatment of complicated intra-abdominal infections in real-life clinical practice from five European observational studies. J Antimicrob Chemother. 2013;68(Suppl 2):ii25–35. doi: 10.1093/jac/dkt142. PubMed DOI

McGovern PC, Wible M, El-Tahtawy A, Biswas P, Meyer RD. All-cause mortality imbalance in the tigecycline phase 3 and 4 clinical trials. Int J Antimicrob Agents. 2013;41:463–7. doi: 10.1016/j.ijantimicag.2013.01.020. PubMed DOI

Falagas ME, Rafailidis PI. Re-emergence of colistin in today’s world of multidrug-resistant organisms: personal perspectives. Expert Opin Investig Drugs. 2008;17:973–81. doi: 10.1517/13543784.17.7.973. PubMed DOI

Falagas ME, Kasiakou SK, Kofteridis DP, Roditakis G, Samonis G. Effectiveness and nephrotoxicity of intravenous colistin for treatment of patients with infections due to polymyxin-only-susceptible (POS) gram-negative bacteria. Eur J Clin Microbiol Infect Dis. 2006;25:596–9. doi: 10.1007/s10096-006-0191-2. PubMed DOI

Ruiz J, Núñez ML, Pérez J, Simarro E, Martínez-Campos L, Gómez J. Evolution of resistance among clinical isolates of Acinetobacter over a 6-year period. Eur J Clin Microbiol Infect Dis. 1999;18:292–5. doi: 10.1007/s100960050280. PubMed DOI

Pontikis K, Karaiskos I, Bastani S, Dimopoulos G, Kalogirou M, Katsiari M, et al. Outcomes of critically ill intensive care unit patients treated with fosfomycin for infections due to pandrug-resistant and extensively drug-resistant carbapenemase-producing Gram-negative bacteria. Int J Antimicrob Agents. 2014;43:52–9. doi: 10.1016/j.ijantimicag.2013.09.010. PubMed DOI

Montravers P, Lepape A, Dubreuil L, Gauzit R, Pean Y, Benchimol D, et al. Clinical and microbiological profiles of community-acquired and nosocomial intra-abdominal infections: results of the French prospective, observational EBIIA study. J Antimicrob Chemother. 2009;63:785–94. doi: 10.1093/jac/dkp005. PubMed DOI

Sitges-Serra A, Lopez MJ, Girvent M, Almirall S, Sancho JJ. Postoperative enterococcal infection after treatment of complicated intra-abdominal sepsis. Br J Surg. 2002;89:361–7. doi: 10.1046/j.0007-1323.2001.02023.x. PubMed DOI

Burnett RJ, Haverstock DC, Dellinger EP, Reinhart HH, Bohnen JM, Rotstein OD, et al. Definition of the role of enterococcus in intraabdominal infection: analysis of a prospective randomized trial. Surgery. 1995;118:716–21. doi: 10.1016/S0039-6060(05)80040-6. PubMed DOI

Dupont H, Friggeri A, Touzeau J, Airapetian N, Tinturier F, Lobjoie E, et al. Enterococci increase the morbidity and mortality associated with severe intra-abdominal infections in elderly patients hospitalized in the intensive care unit. J Antimicrob Chemother. 2011;66:2379–85. doi: 10.1093/jac/dkr308. PubMed DOI

Kaffarnik MF, Urban M, Hopt UT, Utzolino S. Impact of enterococcus on immunocompetent and immunosuppressed patients with perforation of the small or large bowel. Technol Health Care. 2012;20:37–48. PubMed

Noskin GA. Vancomycin-resistant Enterococci: clinical, microbiologic, and epidemiologic features. J Lab Clin Med. 1997;130:14–20. doi: 10.1016/S0022-2143(97)90054-8. PubMed DOI

Birmingham MC, Rayner CR, Meagher AK, Flavin SM, Batts DH, Schentag JJ. Linezolid for the treatment of multidrug-resistant, gram-positive infections: experience from a compassionate-use program. Clin Infect Dis. 2003;36:159–68. doi: 10.1086/345744. PubMed DOI

Knoke M. Gastrointestinal microecology of humans and Candida. Mycoses. 1999;42(Suppl 1):30–4. doi: 10.1111/j.1439-0507.1999.tb04523.x. PubMed DOI

Montravers P, Dupont H, Gauzit R, Veber B, Auboyer C, Blin P, et al. Candida as a risk factor for mortality in peritonitis. Crit Care Med. 2006;34:646–52. doi: 10.1097/01.CCM.0000201889.39443.D2. PubMed DOI

Montravers P, Mira JP, Gangneux JP, Leroy O, Lortholary O, AmarCand study group A multicentre study of antifungal strategies and outcome of Candida spp. peritonitis in intensive-care units. Clin Microbiol Infect. 2011;17:1061–7. doi: 10.1111/j.1469-0691.2010.03360.x. PubMed DOI

Dupont H, Paugam-Burtz C, Muller-Serieys C, Fierobe L, Chosidow D, Marmuse JP, et al. Predictive factors of mortality due to polymicrobial peritonitis with Candida isolation in peritoneal fluid in critically ill patients. Arch Surg. 2002;137:1341–6. doi: 10.1001/archsurg.137.12.1341. PubMed DOI

Bassetti M, Righi E, Ansaldi F, Merelli M, Scarparo C, Antonelli M, et al. A multicenter multinational study of abdominal candidiasis: epidemiology, outcomes and predictors of mortality. Intensive Care Med. 2015;41:1601–10. doi: 10.1007/s00134-015-3866-2. PubMed DOI

Pappas PG, Rotstein CM, Betts RF, Nucci M, Talwar D, De Waele JJ, et al. Micafungin versus caspofungin for treatment of candidemia and other forms of invasive candidiasis. Clin Infect Dis. 2007;45:883–93. doi: 10.1086/520980. PubMed DOI

Kuse ER, Chetchotisakd P, da Cunha CA, Ruhnke M, Barrios C, Raghunadharao D, et al. Micafungin versus liposomal amphotericin B for candidaemia and invasive candidosis: a phase III randomised double-blind trial. Lancet. 2007;369:1519–27. doi: 10.1016/S0140-6736(07)60605-9. PubMed DOI

Lortholary O, Renaudat C, Sitbon K, Madec Y, Denoeud-Ndam L, Wolff M, et al. Worrisome trends in incidence and mortality of candidemia in intensive care units (Paris area, 2002–2010) Intensive Care Med. 2014;40:1303–12. doi: 10.1007/s00134-014-3408-3. PubMed DOI PMC

Kollef M, Micek S, Hampton N, Doherty JA, Kumar A. Septic shock attributed to Candida infection: importance of empiric therapy and source control. Clin Infect Dis. 2012;54:1739–46. doi: 10.1093/cid/cis305. PubMed DOI

Garey KW, Rege M, Pai MP, Mingo DE, Suda KJ, Turpin RS, et al. Time to initiation of fluconazole therapy impacts mortality in patients with candidemia: a multi-institutional study. Clin Infect Dis. 2006;43:25–31. doi: 10.1086/504810. PubMed DOI

EUCAST Clinical breakpoints (Bacterial v 6.0 and Fungal v 8.0): http://www.eucast.org/clinical_breakpoints. Accessed 05 Feb 2017.

Pappas PG, Kauffman CA, Andes DR, Clancy CJ, Marr KA, Ostrosky-Zeichner L, et al. Executive summary: clinical practice guideline for the management of Candidiasis: 2016 update by the Infectious Diseases Society of America. Clin Infect Dis. 2016;62:409–17. doi: 10.1093/cid/civ1194. PubMed DOI

Blot S, De Waele JJ. Critical issues in the clinical management of complicated intra-abdominal infections. Drugs. 2005;65:1611–20. doi: 10.2165/00003495-200565120-00002. PubMed DOI

Bailly S, Leroy O, Montravers P, Constantin JM, Dupont H, Guillemot D, et al. Antifungal de-escalation was not associated with adverse outcome in critically ill patients treated for invasive candidiasis: post hoc analyses of the AmarCAND2 study data. Intensive Care Med. 2015;41:1931–40. doi: 10.1007/s00134-015-4053-1. PubMed DOI

Clyne B, Olshaker JS. The C-reactive protein. J Emerg Med. 1999;17:1019–25. doi: 10.1016/S0736-4679(99)00135-3. PubMed DOI

Sridharan P, Chamberlain RS. The efficacy of procalcitonin as a biomarker in the management of sepsis: slaying dragons or tilting at windmills? Surg Infect (Larchmt) 2013;14:489–511. doi: 10.1089/sur.2012.028. PubMed DOI

Prkno A, Wacker C, Brunkhorst FM, Schlattmann P. Procalcitonin-guided therapy in intensive care unit patients with severe sepsis and septic shock—a systematic review and meta-analysis. Crit Care. 2013;17:R291. doi: 10.1186/cc13157. PubMed DOI PMC

Carr JA. Procalcitonin-guided antibiotic therapy for septic patients in the surgical intensive care unit. J Intensive Care. 2015;3:36. doi: 10.1186/s40560-015-0100-9. PubMed DOI PMC

Jung B, Molinari N, Nasri M, Hajjej Z, Chanques G, Jean-Pierre H, et al. Procalcitonin biomarker kinetics fails to predict treatment response in perioperative abdominal infection with septic shock. Crit Care. 2013;17:R255. doi: 10.1186/cc13082. PubMed DOI PMC

Gross PA, Pujat D. Implementing practice guidelines for appropriate antimicrobial usage: a systematic review. Med Care. 2001;39:II55–II69. PubMed

Davey P, Brown E, Charani E, Fenelon L, Gould IM, Holmes A, et al. Interventions to improve antibiotic prescribing practices for hospital inpatients. Cochrane Database Syst Rev. 2013;4:CD003543. PubMed

Dortch MJ, Fleming SB, Kauffmann RM, Dossett LA, Talbot TR, May AK. Infection reduction strategies including antibiotic stewardship protocols in surgical and trauma intensive care units are associated with reduced resistant gram-negative healthcare-associated infections. Surg Infect (Larchmt) 2011;12:15–25. doi: 10.1089/sur.2009.059. PubMed DOI

Dubrovskaya Y, Papadopoulos J, Scipione MR, Altshuler J, Phillips M, Mehta SA. Antibiotic stewardship for intra-abdominal infections: early impact on antimicrobial use and patient outcomes. Infect Control Hosp Epidemiol. 2012;33:427–9. doi: 10.1086/664765. PubMed DOI

Popovski Z, Mercuri M, Main C, Sne N, Walsh K, Sung M, et al. Multifaceted intervention to optimize antibiotic use for intra-abdominal infections. J Antimicrob Chemother. 2015;70:1226–9. PubMed

Montravers P, Dupont H, Gauzit R, Veber B, Bedos JP, Lepape A, et al. Strategies of initiation and streamlining of antibiotic therapy in 41 French intensive care units. Crit Care. 2011;15:R17. doi: 10.1186/cc9961. PubMed DOI PMC

Leone M, Bourgoin A, Cambon S, Dubuc M, Albanèse J, Martin C. Empirical antimicrobial therapy of septic shock patients: adequacy and impact on the outcome. Crit Care Med. 2003;31:462–7. doi: 10.1097/01.CCM.0000050298.59549.4A. PubMed DOI

Raymond DP, Pelletier SJ, Crabtree TD, Gleason TG, Hamm LL, Pruett TL, et al. Impact of a rotating empiric antibiotic schedule on infectious mortality in an intensive care unit. Crit Care Med. 2001;29:1101–8. doi: 10.1097/00003246-200106000-00001. PubMed DOI

Barie PS, Hydo LJ, Shou J, Larone DH, Eachempati SR. Influence of antibiotic therapy on mortality of critical surgical illness caused or complicated by infection. Surg Infect (Larchmt) 2005;6:41–54. doi: 10.1089/sur.2005.6.41. PubMed DOI

Kullar R, Goff DA, Schulz LT, Fox BC, Rose WE. The “epic” challenge of optimizing antimicrobial stewardship: the role of electronic medical records and technology. Clin Infect Dis. 2013;57:1005–13. doi: 10.1093/cid/cit318. PubMed DOI

Leibovici L, Gitelman V, Yehezkelli Y, Poznanski O, Milo G, Paul M, et al. Improving empirical antibiotic treatment: prospective, nonintervention testing of a decision support system. J Intern Med. 1997;242:395–400. doi: 10.1046/j.1365-2796.1997.00232.x. PubMed DOI

Paul M, Andreassen S, Tacconelli E, Nielsen AD, Almanasreh N, Frank U, et al. Improving empirical antibiotic treatment using TREAT, a computerized decision support system: cluster randomized trial. J Antimicrob Chemother. 2006;58:1238–45. doi: 10.1093/jac/dkl372. PubMed DOI

Pestotnik SL, Classen DC, Evans RS, Burke JP. Implementing antibiotic practice guidelines through computer-assisted decision support: clinical and financial outcomes. Ann Intern Med. 1996;124:884–90. doi: 10.7326/0003-4819-124-10-199605150-00004. PubMed DOI

Halm EA, Atlas SJ, Borowsky LH, Benzer TI, Singer DE. Change in physician knowledge and attitudes after implementation of a pneumonia practice guideline. J Gen Intern Med. 1999;14:688–94. doi: 10.1046/j.1525-1497.1999.03469.x. PubMed DOI PMC

Marrie TJ, Lau CY, Wheeler SL, Wong CJ, Vandervoort MK, Feagan BG. A controlled trial of a critical pathway for treatment of community-acquired pneumonia. CAPITAL Study Investigators. Community-Acquired Pneumonia Intervention Trial Assessing Levofloxacin. JAMA. 2000;283:749–55. doi: 10.1001/jama.283.6.749. PubMed DOI

Weingarten SR, Riedinger MS, Hobson P, Noah MS, Johnson B, Giugliano G, et al. Evaluation of a pneumonia practice guideline in an interventional trial. Am J Respir Crit Care Med. 1996;153:1110–5. doi: 10.1164/ajrccm.153.3.8630553. PubMed DOI

De Waele J, Lipman J, Sakr Y, Marshall JC, Vanhems P, Barrera Groba C, et al. Abdominal infections in the intensive care unit: characteristics, treatment and determinants of outcome. BMC Infect Dis. 2014;14:420. doi: 10.1186/1471-2334-14-420. PubMed DOI PMC

Barie PS, Hydo LJ, Shou J, Larone DH, Eachempati SR. Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock. Crit Care Med. 2006;34:1589–96. doi: 10.1097/01.CCM.0000217961.75225.E9. PubMed DOI

Ferrer R, Martin-Loeches I, Phillips G, Osborn TM, Townsend S, Dellinger RP, et al. Empiric antibiotic treatment reduces mortality in severe sepsis and septic shock from the first hour: results from a guideline-based performance improvement program. Crit Care Med. 2014;42:1749–55. doi: 10.1097/CCM.0000000000000330. PubMed DOI

Garnacho-Montero J, Escoresca-Ortega A, Fernández-Delgado E. Antibiotic de-escalation in the ICU: how is it best done? Curr Opin Infect Dis. 2015;28:193–8. doi: 10.1097/QCO.0000000000000141. PubMed DOI

Garnacho-Montero J, Gutiérrez-Pizarraya A, Escoresca-Ortega A, Corcia-Palomo Y, Fernández-Delgado E, Herrera-Melero I, et al. De-escalation of empirical therapy is associated with lower mortality in patients with severe sepsis and septic shock. Intensive Care Med. 2014;40:32–40. doi: 10.1007/s00134-013-3077-7. PubMed DOI

Leone M, Bechis C, Baumstarck K, Lefrant JY, Albanèse J, Jaber S, et al. De-escalation versus continuation of empirical antimicrobial treatment in severe sepsis: a multicenter non-blinded randomized noninferiority trial. Intensive Care Med. 2014;40:1399–408. doi: 10.1007/s00134-014-3411-8. PubMed DOI

Kaki R, Elligsen M, Walker S, Simor A, Palmay L, Daneman N. Impact of antimicrobial stewardship in critical care: a systematic review. J Antimicrob Chemother. 2011;66:1223–30. doi: 10.1093/jac/dkr137. PubMed DOI

Martín-Loeches I, Diaz E, Vallés J. Risks for multidrug-resistant pathogens in the ICU. Curr Opin Crit Care. 2014;20:516–24. doi: 10.1097/MCC.0000000000000124. PubMed DOI

Bassetti M, De Waele JJ, Eggimann P, Garnacho-Montero J, Kahlmeter G, Menichetti F, et al. Preventive and therapeutic strategies in critically ill patients with highly resistant bacteria. Intensive Care Med. 2015;41:776–95. doi: 10.1007/s00134-015-3719-z. PubMed DOI PMC

Vincent JL, Bassetti M, François B, Karam G, Chastre J, Torres A, et al. Advances in antibiotic therapy in the critically ill. Crit Care. 2016;20:133. doi: 10.1186/s13054-016-1285-6. PubMed DOI PMC

Vincent JL, De Backer D. Circulatory shock. N Engl J Med. 2013;369:1726–34. doi: 10.1056/NEJMra1208943. PubMed DOI

Martin C, Papazian L, Perrin G, Saux P, Gouin F. Norepinephrine or dopamine for the treatment of hyperdynamic septic shock? Chest. 1993;103:1826–31. doi: 10.1378/chest.103.6.1826. PubMed DOI

De Backer D, Aldecoa C, Njimi H, Vincent JL. Dopamine versus norepinephrine in the treatment of septic shock: a meta-analysis. Crit Care Med. 2012;40:725–30. doi: 10.1097/CCM.0b013e31823778ee. PubMed DOI

Sartelli M, Catena F, Di Saverio S, Ansaloni L, Malangoni M, Moore EE, et al. Current concept of abdominal sepsis: WSES position paper. World J Emerg Surg. 2014;9:22. doi: 10.1186/1749-7922-9-22. PubMed DOI PMC

Bailey J, Shapiro MJ. Abdominal compartment syndrome. Crit Care. 2000;4:23–9. doi: 10.1186/cc646. PubMed DOI PMC

Kellum JA, Kong L, Fink MP, Weissfeld LA, Yealy DM, Pinsky MR, et al. Understanding the inflammatory cytokine response in pneumonia and sepsis: results of the Genetic and Inflammatory Markers of Sepsis (GenIMS) Study. Arch Intern Med. 2007;167:1655–63. doi: 10.1001/archinte.167.15.1655. PubMed DOI PMC

Gogos CA, Drosou E, Bassaris HP, Skoutelis A. Pro- versus anti-inflammatory cytokine profile in patients with severe sepsis: a marker for prognosis and future therapeutic options. J Infect Dis. 2000;181:176–80. doi: 10.1086/315214. PubMed DOI

Peng Z, Pai P, Han-Min W, Jun Z, Hong-Bao L, Rong L, et al. Evaluation of the effects of pulse high-volume hemofiltration in patients with severe sepsis: a preliminary study. Int J Artif Organs. 2010;33:505–11. PubMed

Zhou F, Peng Z, Murugan R, Kellum JA. Blood purification and mortality in sepsis: a meta-analysis of randomized trials. Crit Care Med. 2013;41:2209–20. doi: 10.1097/CCM.0b013e31828cf412. PubMed DOI PMC

Cruz DN, Perazella MA, Bellomo R, de Cal M, Polanco N, Corradi V, et al. Effectiveness of polymyxin B-immobilized fiber column in sepsis: a systematic review. Crit Care. 2007;11:R47. doi: 10.1186/cc5780. PubMed DOI PMC

Cruz DN, Antonelli M, Fumagalli R, Foltran F, Brienza N, Donati A, et al. Early use of polymyxin B hemoperfusion in abdominal septic shock: the EUPHAS randomized controlled trial. JAMA. 2009;301:2445–52. doi: 10.1001/jama.2009.856. PubMed DOI

Payen DM, Guilhot J, Launey Y, Lukaszewicz AC, Kaaki M, Veber B, et al. Early use of polymyxin B hemoperfusion in patients with septic shock due to peritonitis: a multicenter randomized control trial. Intensive Care Med. 2015;41:975–84. doi: 10.1007/s00134-015-3751-z. PubMed DOI PMC

Klein DJ, Foster D, Schorr CA, Kazempour K, Walker PM, Dellinger RP. The EUPHRATES trial (Evaluating the Use of Polymyxin B Hemoperfusion in a Randomized controlled trial of Adults Treated for Endotoxemia and Septic shock): study protocol for a randomized controlled trial. Trials. 2014;15:218. doi: 10.1186/1745-6215-15-218. PubMed DOI PMC

Rodríguez A, Rello J, Neira J, Maskin B, Ceraso D, Vasta L, et al. Effects of high-dose of intravenous immunoglobulin and antibiotics on survival for severe sepsis undergoing surgery. Shock. 2005;23:298–304. doi: 10.1097/01.shk.0000157302.69125.f8. PubMed DOI

Alejandria MM, Lansang MA, Dans LF, 3rd Mantaring JB. Intravenous immunoglobulin for treating sepsis, severe sepsis and septic shock. Cochrane Database Syst Rev. 2013;9:CD001090. PubMed PMC

Busani S, Damiani E, Cavazzuti I, Donati A, Girardis M. Intravenous immunoglobulin in septic shock: review of the mechanisms of action and meta-analysis of the clinical effectiveness. Minerva Anestesiol. 2016;82:559–72. PubMed

Kreymann KG, de Heer G, Nierhaus A, Kluge S. Use of polyclonal immunoglobulins as adjunctive therapy for sepsis or septic shock. Crit Care Med. 2007;35:2677–85. doi: 10.1097/01.CCM.0000295263.12774.97. PubMed DOI

Xiao Z, Wilson C, Robertson HL, Roberts DJ, Ball CG, Jenne CN, et al. Inflammatory mediators in intra-abdominal sepsis or injury—a scoping review. Crit Care. 2015;19:373. doi: 10.1186/s13054-015-1093-4. PubMed DOI PMC

Schentag JJ, O’Keeffe D, Marmion M, Wels PB. C-reactive protein as an indicator of infection relapse in patients with abdominal sepsis. Arch Surg. 1984;119:300–4. doi: 10.1001/archsurg.1984.01390150040010. PubMed DOI

Almeida AB, Faria G, Moreira H, Pinto-de-Sousa J, Correia-da-Silva P, Maia JC. Elevated serum C-reactive protein as a predictive factor for anastomotic leakage in colorectal surgery. Int J Surg. 2012;10:87–91. doi: 10.1016/j.ijsu.2011.12.006. PubMed DOI

Witczak A, Juralowicz P, Modzelewski B, Gawlik M. C-reactive protein as a marker of postoperative septic complications. Pol Przegl Chir. 2012;84:93–8. PubMed

Scepanovic MS, Kovacevic B, Cijan V, Antic A, Petrovic Z, Asceric R, et al. C-reactive protein as an early predictor for anastomotic leakage in elective abdominal surgery. Tech coloproctol. 2013;17:541–7. doi: 10.1007/s10151-013-1013-z. PubMed DOI

Kaufmann P, Tilz GP, Smolle KH, Demel U, Krejs GJ. Increased plasma concentrations of circulating intercellular adhesion molecule-1 (cICAM-1) in patients with necrotizing pancreatitis. Immunobiology. 1996;195:209–19. doi: 10.1016/S0171-2985(96)80040-4. PubMed DOI

Celik IH, Yilmaz Y, Erdeve O, Demirel G, Oguz SS, Uras N, et al. The acute-phase response in differentiating sepsis from inflammation in neonates who require abdominal surgery. Acta Chir Belg. 2012;112:292–6. PubMed

Tschaikowsky K, Hedwig-Geissing M, Braun GG, Radespiel-Troeger M. Predictive value of procalcitonin, interleukin-6, and C-reactive protein for survival in postoperative patients with severe sepsis. J Crit Care. 2011;26:54–64. doi: 10.1016/j.jcrc.2010.04.011. PubMed DOI

Mokart D, Merlin M, Sannini A, Brun JP, Delpero JR, Houvenaeghel G, et al. Procalcitonin, interleukin 6 and systemic inflammatory response syndrome (SIRS): early markers of postoperative sepsis after major surgery. Br J Anaesth. 2005;94:767–73. doi: 10.1093/bja/aei143. PubMed DOI

Reith HB, Mittelkotter U, Wagner R, Thiede A. Procalcitonin (PCT) in patients with abdominal sepsis. Intensive Care Med. 2000;26(Suppl 2):S165–9. doi: 10.1007/s001340051137. PubMed DOI

Novotny AR, Emmanuel K, Hueser N, Knebel C, Kriner M, Ulm K, et al. Procalcitonin ratio indicates successful surgical treatment of abdominal sepsis. Surgery. 2009;145:20–6. doi: 10.1016/j.surg.2008.08.009. PubMed DOI

Bezmarevic M, Mirkovic D, Soldatovic I, Stamenkovic D, Mitrovic N, Perisic N, et al. Correlation between procalcitonin and intra-abdominal pressure and their role in prediction of the severity of acute pancreatitis. Pancreatology. 2012;12:337–43. doi: 10.1016/j.pan.2012.05.007. PubMed DOI

Barbić J, Ivić D, Alkhamis T, Drenjancević D, Ivić J, Harsanji-Drenjancević I, et al. Kinetics of changes in serum concentrations of procalcitonin, interleukin-6, and C- reactive protein after elective abdominal surgery. Can it be used to detect postoperative complications? Coll Antropol. 2013;37:195–201. PubMed

Ravishankaran P, Shah AM, Bhat R. Correlation of interleukin-6, serum lactate, and C-reactive protein to inflammation, complication, and outcome during the surgical course of patients with acute abdomen. J Interferon Cytokine Res. 2011;31:685–90. doi: 10.1089/jir.2011.0021. PubMed DOI

Yamamoto T, Umegae S, Matsumoto K, Saniabadi AR. Peritoneal cytokines as early markers of peritonitis following surgery for colorectal carcinoma: a prospective study. Cytokine. 2011;53:239–42. doi: 10.1016/j.cyto.2010.10.006. PubMed DOI

Steppan J, Hofer S, Funke B, Brenner T, Henrich M, Martin E, et al. Sepsis and major abdominal surgery lead to flaking of the endothelial glycocalix. J Surg Res. 2011;165:136–41. doi: 10.1016/j.jss.2009.04.034. PubMed DOI

Yamamoto T, Umegae S, Kitagawa T, Matsumoto K. Intraperitoneal cytokine productions and their relationship to peritoneal sepsis and systemic inflammatory markers in patients with inflammatory bowel disease. Dis Colon Rectum. 2005;48:1005–15. doi: 10.1007/s10350-004-0866-7. PubMed DOI

Sarbinowski R, Arvidsson S, Tylman M, Oresland T, Bengtsson A. Plasma concentration of procalcitonin and systemic inflammatory response syndrome after colorectal surgery. Acta Anaesthesiol Scand. 2005;49:191–6. doi: 10.1111/j.1399-6576.2004.00565.x. PubMed DOI

Manganelli V, Signore M, Pacini I, Misasi R, Tellan G, Garofalo T, et al. Increased HMGB1 expression and release by mononuclear cells following surgical/anesthesia trauma. Crit Care. 2010;14:R197. doi: 10.1186/cc9316. PubMed DOI PMC

Albayrak Y, Albayrak A, Celik M, Gelincik I, Demiryilmaz I, Yildirim R, et al. High mobility group box protein-1 (HMGB-1) as a new diagnostic marker in patients with acute appendicitis. Scand J Trauma Resusc Emerg Med. 2011;19:27. doi: 10.1186/1757-7241-19-27. PubMed DOI PMC

Scheingraber S, Bauerfeind F, Bohme J, Dralle H. Limits of peritoneal cytokine measurements during abdominal lavage treatment for intraabdominal sepsis. Am J Surg. 2001;181:301–8. doi: 10.1016/S0002-9610(01)00587-6. PubMed DOI

Jansson K, Redler B, Truedsson L, Magnuson A, Matthiessen P, Andersson M, et al. Intraperitoneal cytokine response after major surgery: higher postoperative intraperitoneal versus systemic cytokine levels suggest the gastrointestinal tract as the major source of the postoperative inflammatory reaction. Am J Surg. 2004;187:372–7. doi: 10.1016/j.amjsurg.2003.12.019. PubMed DOI

Hendriks T, Bleichrodt RP, Lomme RM, De Man BM, van Goor H, Buyne OR. Peritoneal cytokines predict mortality after surgical treatment of secondary peritonitis in the rat. J Am Coll Surg. 2010;211:263–70. doi: 10.1016/j.jamcollsurg.2010.03.038. PubMed DOI

Holzheimer RG, Schein M, Wittmann DH. Inflammatory response in peritoneal exudate and plasma of patients undergoing planned relaparotomy for severe secondary peritonitis. Arch Surg. 1995;130:1314–9. doi: 10.1001/archsurg.1995.01430120068010. PubMed DOI

Fink MP, Delude RL. Epithelial barrier dysfunction: a unifying theme to explain the pathogenesis of multiple organ dysfunction at the celllular level. Crit Care Clin. 2005;21:177–96. doi: 10.1016/j.ccc.2005.01.005. PubMed DOI

Mayberry JC, Welker KJ, Goldman RK, Mullins RJ. Mechanism of acute ascities formation after trauma resuscitation. Arch Surg. 2003;138:773–6. doi: 10.1001/archsurg.138.7.773. PubMed DOI

Marshall JC, Vincent JL, Fink MP, Cook DJ, Rubenfeld G, Foster D, et al. Measures, markers, and mediators: toward a staging system for clinical sepsis. A report of the Fifth Toronto Sepsis Roundtable, Toronto, Ontario, Canada, October 25–26, 2000. Crit Care Med. 2003;31:1560–7. doi: 10.1097/01.CCM.0000065186.67848.3A. PubMed DOI

Johnson D, Mayers I. Multiple organ dysfunction syndrome: a narrative review. Can J Anaesth. 2001;48:502–9. doi: 10.1007/BF03028318. PubMed DOI

Suliburk J, Helmer K, Moore F, Mercer D. The gut in systemic inflammatory response syndrome and sepsis. Enzyme systems fighting multiple organ failure. Eur Surg Res. 2008;40:184–9. doi: 10.1159/000110859. PubMed DOI

Deitch EA. Role of the gut lymphatic system in multiple organ failure. Curr Opin Crit Care. 2001;7:92–8. doi: 10.1097/00075198-200104000-00007. PubMed DOI

Cavriani G, Domingos HV, Soares AL, Trezena AG, Ligeiro-Oliveira AP, Oliveira-Filho RM, et al. Lymphatic system as a path underlying the spread of lung and gut injury after intestinal ischemia/reperfusion in rats. Shock. 2005;23:330–6. doi: 10.1097/01.shk.0000157303.76749.9b. PubMed DOI

Latenser BA, Kowal-Vern A, Kimball D, Chakrin A, Dujovny N. A pilot study comparing percutaneous decompression with decompressive laparotomy for acute abdominal compartment syndrome in thermal injury. J Burn Care Rehabil. 2002;23:190–5. doi: 10.1097/00004630-200205000-00008. PubMed DOI

WSES/GAIS/SIS-E/WSIS/AAST global clinical pathways for patients with intra-abdominal infections

2020 update of the WSES guidelines for the management of acute colonic diverticulitis in the emergency setting

Physiological parameters for Prognosis in Abdominal Sepsis (PIPAS) Study: a WSES observational study

Raising concerns about the Sepsis-3 definitions